{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:14:42Z","timestamp":1790813682448,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Programa SEC-CNIC Cardiojoven"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00395-017-0662-x","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T08:50:10Z","timestamp":1510735810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":173,"title":["The RISK pathway and beyond"],"prefix":"10.1007","volume":"113","author":[{"given":"Xavier","family":"Rossello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"662_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/cvr\/cvv171","volume":"107","author":"JJ Alburquerque-B\u00e9jar","year":"2015","unstructured":"Alburquerque-B\u00e9jar JJ, Barba I, Inserte J, Mir\u00f3-Casas E, Ruiz-Meana M, Poncelas M, Vilardosa \u00da, Valls-Lacalle L, Rodr\u00edguez-Sinovas A, Garcia-Dorado D (2015) Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs. Cardiovasc Res 107:246\u2013254. \n                        https:\/\/doi.org\/10.1093\/cvr\/cvv171","journal-title":"Cardiovasc Res"},{"key":"662_CR2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/00005344-200112000-00015","volume":"38","author":"GF Baxter","year":"2001","unstructured":"Baxter GF, Mocanu MM, Brar BK, Latchman DS, Yellon DM (2001) Cardioprotective effects of transforming growth factor-beta1 during early reoxygenation or reperfusion are mediated by p42\/p44 MAPK. J Cardiovasc Pharmacol 38:930\u2013939","journal-title":"J Cardiovasc Pharmacol"},{"key":"662_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00395-013-0331-7","volume":"108","author":"RM Bell","year":"2013","unstructured":"Bell RM, Kunuthur SP, Hendry C, Bruce-Hickman D, Davidson S, Yellon DM (2013) Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK\/mPTP signalling: a parallel pathway to protection. Basic Res Cardiol 108:331. \n                        https:\/\/doi.org\/10.1007\/s00395-013-0331-7","journal-title":"Basic Res Cardiol"},{"key":"662_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.bjp.0707453","volume":"152","author":"MV Cohen","year":"2007","unstructured":"Cohen MV, Downey JM (2007) Cardioprotection: spotlight on PKG. Br J Pharmacol 152:833\u2013834. \n                        https:\/\/doi.org\/10.1038\/sj.bjp.0707453","journal-title":"Br J Pharmacol"},{"key":"662_CR5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.biocel.2005.09.017","volume":"38","author":"SM Davidson","year":"2006","unstructured":"Davidson SM, Hausenloy D, Duchen MR, Yellon DM (2006) Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 38:414\u2013419. \n                        https:\/\/doi.org\/10.1016\/j.biocel.2005.09.017","journal-title":"Int J Biochem Cell Biol"},{"key":"662_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/jkst.20072","volume":"1","author":"SM Davidson","year":"2012","unstructured":"Davidson SM, Yellon DM (2012) STAT5 fits the RISK profile for cardioprotection. JAK-STAT 1:73\u201376. \n                        https:\/\/doi.org\/10.4161\/jkst.20072","journal-title":"JAK-STAT"},{"key":"662_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrcardio.2014.137","volume":"11","author":"V Fuster","year":"2014","unstructured":"Fuster V (2014) Top 10 cardiovascular therapies and interventions for the next decade. Nat Rev Cardiol 11:671\u2013683. \n                        https:\/\/doi.org\/10.1038\/nrcardio.2014.137","journal-title":"Nat Rev Cardiol"},{"key":"662_CR8","doi-asserted-by":"publisher","first-page":"H478","DOI":"10.1152\/ajpheart.00749.2016","volume":"312","author":"S Gent","year":"2017","unstructured":"Gent S, Skyschally A, Kleinbongard P, Heusch G (2017) Ischemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3. Am J Physiol Heart Circ Physiol 312:H478\u2013H484. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00749.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"662_CR9","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jama.293.8.979","volume":"293","author":"BJ Gersh","year":"2005","unstructured":"Gersh BJ, Stone GW, White HD, Holmes DR (2005) Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 293:979\u2013986. \n                        https:\/\/doi.org\/10.1001\/jama.293.8.979","journal-title":"JAMA"},{"key":"662_CR10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.103.5.670","volume":"103","author":"S Haq","year":"2001","unstructured":"Haq S, Choukroun G, Lim H, Tymitz KM, Del-Monte F, Gwathmey J, Grazette L, Michael A, Hajjar R, Force T, Molkentin JD (2001) Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103:670\u2013677","journal-title":"Circulation"},{"key":"662_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00395-016-0588-8","volume":"111","author":"DJ Hausenloy","year":"2016","unstructured":"Hausenloy DJ, Barrabes JA, Botker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, Kharbanda R, Lecour S, Marber M, Miura T, Ovize M, Perez-Pinzon MA, Piper HM, Przyklenk K, Schmidt MR, Redington A, Ruiz-Meana M, Vilahur G, Vinten-Johansen J, Yellon DM, Garcia-Dorado D (2016) Ischaemic conditioning and targeting reperfusion injury: a 30\u00a0year voyage of discovery. Basic Res Cardiol 111:70. \n                        https:\/\/doi.org\/10.1007\/s00395-016-0588-8","journal-title":"Basic Res Cardiol"},{"key":"662_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.cardiores.2003.09.025","volume":"60","author":"DJ Hausenloy","year":"2003","unstructured":"Hausenloy DJ, Duchen MR, Yellon DM (2003) Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia\u2013reperfusion injury. Cardiovasc Res 60:617\u2013625. \n                        https:\/\/doi.org\/10.1016\/j.cardiores.2003.09.025","journal-title":"Cardiovasc Res"},{"key":"662_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10557-011-6364-y","volume":"26","author":"DJ Hausenloy","year":"2012","unstructured":"Hausenloy DJ, Iliodromitis EK, Andreadou I, Papalois A, Gritsopoulos G, Anastasiou-Nana M, Kremastinos DT, Yellon DM (2012) Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther 26:87\u201393. \n                        https:\/\/doi.org\/10.1007\/s10557-011-6364-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"662_CR14","doi-asserted-by":"publisher","first-page":"H971","DOI":"10.1152\/ajpheart.00374.2004","volume":"288","author":"DJ Hausenloy","year":"2005","unstructured":"Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288:H971\u2013H976. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00374.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"662_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tcm.2005.03.001","volume":"15","author":"DJ Hausenloy","year":"2005","unstructured":"Hausenloy DJ, Tsang A, Yellon DM (2005) The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15:69\u201375. \n                        https:\/\/doi.org\/10.1016\/j.tcm.2005.03.001","journal-title":"Trends Cardiovasc Med"},{"key":"662_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","volume":"116","author":"G Heusch","year":"2015","unstructured":"Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674\u2013699. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305348","journal-title":"Circ Res"},{"key":"662_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/eurheartj\/ehw224","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38:774\u2013784. \n                        https:\/\/doi.org\/10.1093\/eurheartj\/ehw224","journal-title":"Eur Heart J"},{"key":"662_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1161\/CIRCRESAHA.111.259556","volume":"110","author":"G Heusch","year":"2012","unstructured":"Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M (2012) STAT5 activation and cardioprotection by remote ischemic preconditioning in humans novelty and significance. Circ Res 110:111\u2013115. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.259556","journal-title":"Circ Res"},{"key":"662_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1161\/01.CIR.0000081943.93653.73","volume":"108","author":"K Inagaki","year":"2003","unstructured":"Inagaki K (2003) Additive protection of the ischemic heart ex vivo by combined treatment with -protein kinase C inhibitor and -protein kinase C activator. Circulation 108:869\u2013875. \n                        https:\/\/doi.org\/10.1161\/01.CIR.0000081943.93653.73","journal-title":"Circulation"},{"key":"662_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1161\/hh2401.101385","volume":"89","author":"AK Jonassen","year":"2001","unstructured":"Jonassen AK, Sack MN, Mj\u00f8s OD, Yellon DM (2001) Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 89:1191\u20131198. \n                        https:\/\/doi.org\/10.1161\/hh2401.101385","journal-title":"Circ Res"},{"key":"662_CR21","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/ATVBAHA.111.224915","volume":"32","author":"K Konstantinidis","year":"2012","unstructured":"Konstantinidis K, Whelan RS, Kitsis RN (2012) Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 32:1552\u20131562. \n                        https:\/\/doi.org\/10.1161\/ATVBAHA.111.224915","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"662_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cvr\/cvp274","volume":"84","author":"L Lacerda","year":"2009","unstructured":"Lacerda L, Somers S, Opie LH, Lecour S (2009) Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84:201\u2013208. \n                        https:\/\/doi.org\/10.1093\/cvr\/cvp274","journal-title":"Cardiovasc Res"},{"key":"662_CR23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.yjmcc.2009.01.003","volume":"46","author":"S Lecour","year":"2009","unstructured":"Lecour S (2009) Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? J Mol Cell Cardiol 46:607\u2013609. \n                        https:\/\/doi.org\/10.1016\/j.yjmcc.2009.01.003","journal-title":"J Mol Cell Cardiol"},{"key":"662_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2009.03.019","volume":"47","author":"S Lecour","year":"2009","unstructured":"Lecour S (2009) Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: does it go beyond the RISK pathway? J Mol Cell Cardiol 47:32\u201340. \n                        https:\/\/doi.org\/10.1016\/j.yjmcc.2009.03.019","journal-title":"J Mol Cell Cardiol"},{"key":"662_CR25","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1161\/CIRCULATIONAHA.105.581058","volume":"112","author":"S Lecour","year":"2005","unstructured":"Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, Opie LH (2005) Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 112:3911\u20133918. \n                        https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.581058","journal-title":"Circulation"},{"key":"662_CR26","doi-asserted-by":"publisher","first-page":"H1923","DOI":"10.1152\/ajpheart.00935.2003","volume":"286","author":"JD McCully","year":"2004","unstructured":"McCully JD, Wakiyama H, Hsieh Y-J, Jones M, Levitsky S (2004) Differential contribution of necrosis and apoptosis in myocardial ischemia\u2013reperfusion injury. Am J Physiol Heart Circ Physiol 286:H1923\u2013H1935. \n                        https:\/\/doi.org\/10.1152\/ajpheart.00935.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"662_CR27","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jacc.2005.01.021","volume":"45","author":"K Mensah","year":"2005","unstructured":"Mensah K, Mocanu MM, Yellon DM (2005) Failure to protect the myocardium against ischemia\/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 45:1287\u20131291. \n                        https:\/\/doi.org\/10.1016\/j.jacc.2005.01.021","journal-title":"J Am Coll Cardiol"},{"key":"662_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/sj.bjp.0703336","volume":"130","author":"MM Mocanu","year":"2000","unstructured":"Mocanu MM, Baxter GF, Yellon DM (2000) Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 130:197\u2013200. \n                        https:\/\/doi.org\/10.1038\/sj.bjp.0703336","journal-title":"Br J Pharmacol"},{"key":"662_CR29","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","volume":"74","author":"CE Murry","year":"1986","unstructured":"Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124\u20131136. \n                        https:\/\/doi.org\/10.1161\/01.CIR.74.5.1124","journal-title":"Circulation"},{"key":"662_CR30","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1172\/JCI23073","volume":"115","author":"T Nagoshi","year":"2005","unstructured":"Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, Del-Monte F, Gwathmey JK, Grazette L, Hemmings BA, Hemmings B, Kass DA, Champion HC, Rosenzweig A (2005) PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia\/reperfusion injury. J Clin Invest 115:2128\u20132138. \n                        https:\/\/doi.org\/10.1172\/JCI23073","journal-title":"J Clin Invest"},{"key":"662_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13394","author":"X Rossello","year":"2017","unstructured":"Rossello X, Riquelme JA, Davidson SM, Yellon DM (2017) Role of PI3K in myocardial ischaemic preconditioning: mapping pro-survival cascades at the trigger phase and at reperfusion. J Cell Mol Med. \n                        https:\/\/doi.org\/10.1111\/jcmm.13394","journal-title":"J Cell Mol Med"},{"key":"662_CR32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00395-017-0657-7","volume":"112","author":"X Rossello","year":"2017","unstructured":"Rossello X, Riquelme JA, He Z, Taferner S, Vanhaesebroeck B, Davidson SM, Yellon DM (2017) The role of PI3K\u03b1 isoform in cardioprotection. Basic Res Cardiol 112:66. \n                        https:\/\/doi.org\/10.1007\/s00395-017-0657-7","journal-title":"Basic Res Cardiol"},{"key":"662_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijcard.2016.06.131","volume":"220","author":"X Rossello","year":"2016","unstructured":"Rossello X, Yellon DM (2016) A critical review on the translational journey of cardioprotective therapies! Int J Cardiol 220:176\u2013184. \n                        https:\/\/doi.org\/10.1016\/j.ijcard.2016.06.131","journal-title":"Int J Cardiol"},{"key":"662_CR34","doi-asserted-by":"publisher","first-page":"H1481","DOI":"10.1152\/ajpheart.01089.2001","volume":"283","author":"D Schulman","year":"2002","unstructured":"Schulman D, Latchman DS, Yellon DM (2002) Urocortin protects the heart from reperfusion injury via upregulation of p42\/p44 MAPK signaling pathway. Am J Physiol Heart Circ Physiol 283:H1481\u2013H1488. \n                        https:\/\/doi.org\/10.1152\/ajpheart.01089.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"662_CR35","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1111\/j.1582-4934.2009.00796.x","volume":"14","author":"V Sivaraman","year":"2010","unstructured":"Sivaraman V, Hausenloy DJ, Wynne AM, Yellon DM (2010) Preconditioning the diabetic human myocardium. J Cell Mol Med 14:1740\u20131746. \n                        https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00796.x","journal-title":"J Cell Mol Med"},{"key":"662_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCRESAHA.108.186429","volume":"104","author":"A Skyschally","year":"2009","unstructured":"Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, Schulz R, Heusch G (2009) Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 104:15\u201318. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.108.186429","journal-title":"Circ Res"},{"key":"662_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCRESAHA.117.306878","volume":"117","author":"A Skyschally","year":"2015","unstructured":"Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G (2015) Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways novelty and significance. Circ Res 117:279\u2013288. \n                        https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.306878","journal-title":"Circ Res"},{"key":"662_CR38","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/j.1582-4934.2011.01341.x","volume":"15","author":"CCT Smith","year":"2011","unstructured":"Smith CCT, Yellon DM (2011) Necroptosis, necrostatins and tissue injury. J Cell Mol Med 15:1797\u20131806. \n                        https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01341.x","journal-title":"J Cell Mol Med"},{"key":"662_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/cvr\/cvn067","volume":"79","author":"N Suleman","year":"2008","unstructured":"Suleman N, Somers S, Smith R, Opie LH, Lecour SC (2008) Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Cardiovasc Res 79:127\u2013133. \n                        https:\/\/doi.org\/10.1093\/cvr\/cvn067","journal-title":"Cardiovasc Res"},{"key":"662_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.tcm.2012.02.002","volume":"21","author":"M Takahashi","year":"2011","unstructured":"Takahashi M (2011) Role of the inflammasome in myocardial infarction. Trends Cardiovasc Med 21:37\u201341. \n                        https:\/\/doi.org\/10.1016\/j.tcm.2012.02.002","journal-title":"Trends Cardiovasc Med"},{"key":"662_CR41","doi-asserted-by":"publisher","first-page":"e0142021","DOI":"10.1371\/journal.pone.0142021","volume":"10","author":"KE Wever","year":"2015","unstructured":"Wever KE, Hooijmans CR, Riksen NP, Sterenborg TB, Sena ES, Ritskes-Hoitinga M, Warl\u00e9 MC (2015) Determinants of the efficacy of cardiac ischemic preconditioning: a systematic review and meta-analysis of animal studies. PLoS ONE 10:e0142021. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0142021","journal-title":"PLoS ONE"},{"key":"662_CR42","doi-asserted-by":"publisher","first-page":"e32296","DOI":"10.1371\/journal.pone.0032296","volume":"7","author":"KE Wever","year":"2012","unstructured":"Wever KE, Menting TP, Rovers M, van der Vliet JA, Rongen GA, Masereeuw R, Ritskes-Hoitinga M, Hooijmans CR, Warl\u00e9 M (2012) Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS ONE 7:e32296. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0032296","journal-title":"PLoS ONE"},{"key":"662_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0140-6736(93)91819-8","volume":"342","author":"DM Yellon","year":"1993","unstructured":"Yellon DM, Alkhulaifi AM, Pugsley WB (1993) Preconditioning the human myocardium. Lancet 342:276\u2013277. \n                        https:\/\/doi.org\/10.1016\/0140-6736(93)91819-8","journal-title":"Lancet"},{"key":"662_CR44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1050-1738(00)00029-3","volume":"9","author":"DM Yellon","year":"1999","unstructured":"Yellon DM, Baxter GF (1999) Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 9:245\u2013249","journal-title":"Trends Cardiovasc Med"},{"key":"662_CR45","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357:1121\u20131135. \n                        https:\/\/doi.org\/10.1056\/NEJMra071667","journal-title":"N Engl J Med"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-017-0662-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-017-0662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-017-0662-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T17:25:39Z","timestamp":1515432339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-017-0662-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["662"],"URL":"https:\/\/doi.org\/10.1007\/s00395-017-0662-x","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]},"article-number":"2"}}